Acorda Therapeutics, Inc. Debt Conversion, Original Debt, Amount
Acorda Therapeutics, Inc. reported Debt Conversion, Original Debt, Amount of $69.00 million for the 9-month period ending 2020-09-30, per its 10-Q filed 2020-11-06.
Discontinued › Cash Flow › Financing Activities
us-gaap:DebtConversionOriginalDebtAmount1 · last filed 2020-11-06
- 2020-09-30: Debt Conversion, Original Debt, Amount 9 month $69.00M.
| Period end | Debt Conversion, Original Debt, Amount 9 month |
|---|---|
| 2020-09-30 | $69.00M 10-Q · filed 2020-11-06 |